Innovative Sterilization CatheCare's pioneering CASS device offers a highly effective solution that eradicates 99.9% of bacteria and provides continuous sterilization, addressing critical hospital safety needs and reducing the incidence of life-threatening CRBSIs.

Growth Potential With an annual revenue range between 1 to 10 million dollars and a specialized, high-impact product, CatheCare presents an attractive opportunity for strategic partners and investors aiming to advance healthcare safety innovations.

Healthcare Impact Targeting a major unmet need in infection prevention for millions of patients requiring central venous catheters annually, CatheCare's solution has the potential to significantly improve patient outcomes and hospital efficiency.

Technological Approach Utilizing advanced tech stacks including React and Nginx, CatheCare demonstrates a modern, scalable approach to medical device development, which can facilitate integration with hospital systems and other digital health tools.

Market Expansion Given the high prevalence of CVC procedures and the urgent need for infection control, CatheCare is well-positioned to expand into larger hospital markets and forge partnerships with device manufacturers or healthcare systems seeking innovative sterilization solutions.